Cipla Ltd. Logo

Cipla Ltd. (CIPLA)

BSE

Currency in INR
1,412.40
-7.60 (-0.54%)

Closed

Aug 26, 2026

Day's Range

1,400.40
1,419.05

52 wk Range

1,165.55
1,672.20

Overview - CIPLA - Cipla Ltd.

Key Statistics

Valuation

Enterprise Value

976.22B

P/E (Trailing)

‪25.39‬

P/E (Forward)

‪25.19‬

PEG Ratio

‪25.19‬

Price / Sales (TTM)

‪4.12‬

Price / Book

‪3.50‬

EV / EBITDA

‪15.32‬

Profitability

Gross Margin

‪62.31%‬

Profit Margin

‪16.25%‬

Operating Margin

‪14.02%‬

Ownership

Shares Outstanding

807.78M

Float

563.37M

Held by Insiders

‪30.78%‬

Held by Institutions

‪40.33%‬

Price stats

Beta

‪-0.05‬

50-Day Avg

‪1,456.22‬

200-Day Avg

‪1,507.22‬

Dividends

Payout Ratio

‪23.11%‬

Frequency

Annual

Analyst Consensus

Hold

36 analysts

Average price target

‪₹ 1,458.53‬

Market Cap - CIPLA - Cipla Ltd.

Peers - CIPLA - Cipla Ltd.

Peer Comparison

Compared with companies in Drug Manufacturers - Specialty & Generic listed on BSE.

Profile Summary - CIPLA - Cipla Ltd.

About

Cipla Ltd. is an Indian pharmaceutical company that develops, manufactures, and markets a broad range of medicines and healthcare products for patients and healthcare providers worldwide. Its current business centers on pharmaceuticals and new ventures, with a portfolio that includes generic medicines, active…

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees30.31K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.